Cargando…
Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660393/ https://www.ncbi.nlm.nih.gov/pubmed/38024610 http://dx.doi.org/10.1002/jha2.767 |
| _version_ | 1785137749003599872 |
|---|---|
| author | Tiong, Ing S. Stevenson, William S. Wall, Meaghan Yap, Yan Zhuang Seymour, John F. Kenealy, Melita Blombery, Piers |
| author_facet | Tiong, Ing S. Stevenson, William S. Wall, Meaghan Yap, Yan Zhuang Seymour, John F. Kenealy, Melita Blombery, Piers |
| author_sort | Tiong, Ing S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10660393 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106603932023-08-25 Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide Tiong, Ing S. Stevenson, William S. Wall, Meaghan Yap, Yan Zhuang Seymour, John F. Kenealy, Melita Blombery, Piers EJHaem Correspondence John Wiley and Sons Inc. 2023-08-25 /pmc/articles/PMC10660393/ /pubmed/38024610 http://dx.doi.org/10.1002/jha2.767 Text en © 2023 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondence Tiong, Ing S. Stevenson, William S. Wall, Meaghan Yap, Yan Zhuang Seymour, John F. Kenealy, Melita Blombery, Piers Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide |
| title | Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide |
| title_full | Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide |
| title_fullStr | Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide |
| title_full_unstemmed | Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide |
| title_short | Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide |
| title_sort | favorable outcomes of ddx41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660393/ https://www.ncbi.nlm.nih.gov/pubmed/38024610 http://dx.doi.org/10.1002/jha2.767 |
| work_keys_str_mv | AT tiongings favorableoutcomesofddx41mutatedmyelodysplasticsyndromeandlowblastcountacutemyeloidleukemiatreatedwithazacitidinelenalidomide AT stevensonwilliams favorableoutcomesofddx41mutatedmyelodysplasticsyndromeandlowblastcountacutemyeloidleukemiatreatedwithazacitidinelenalidomide AT wallmeaghan favorableoutcomesofddx41mutatedmyelodysplasticsyndromeandlowblastcountacutemyeloidleukemiatreatedwithazacitidinelenalidomide AT yapyanzhuang favorableoutcomesofddx41mutatedmyelodysplasticsyndromeandlowblastcountacutemyeloidleukemiatreatedwithazacitidinelenalidomide AT seymourjohnf favorableoutcomesofddx41mutatedmyelodysplasticsyndromeandlowblastcountacutemyeloidleukemiatreatedwithazacitidinelenalidomide AT kenealymelita favorableoutcomesofddx41mutatedmyelodysplasticsyndromeandlowblastcountacutemyeloidleukemiatreatedwithazacitidinelenalidomide AT blomberypiers favorableoutcomesofddx41mutatedmyelodysplasticsyndromeandlowblastcountacutemyeloidleukemiatreatedwithazacitidinelenalidomide AT favorableoutcomesofddx41mutatedmyelodysplasticsyndromeandlowblastcountacutemyeloidleukemiatreatedwithazacitidinelenalidomide |